Methotrexate May Benefit Juvenile Scleroderma
October 7, 2010|Rheumatology News
Author and Disclosure Information
Children with localized scleroderma responded better to methotrexate than to prednisone in a small, placebo-controlled trial, Dr. Francesco Zulian reports.